📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nuvalent

1.1 - Company Overview

Nuvalent Logo

Nuvalent

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of targeted therapies for clinically proven kinase targets in cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nuvalent

Shattuck Labs Logo

Shattuck Labs

HQ: United States Website
  • Description: Provider of novel biologic medicines for cancer and autoimmune diseases, leveraging the ARC platform to create bi-functional fusion proteins combining immune checkpoint blockade with TNF costimulation. Pipeline includes SL-172154 (SIRPα-Fc-CD40L) in Phase 1 targeting CD47 on malignant cells and CD40 on immune cells for ovarian cancer and AML/HR-MDS, plus over 400 candidates across validated and emerging pathways.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Shattuck Labs company profile →
Affimed Logo

Affimed

HQ: Germany Website
  • Description: Provider of innate cell engager (ICE) antibody therapeutics for cancer, including AFM13 (CD30/CD16A), AFM24 (EGFR-directed engaging NK cells and macrophages), and AFM28 (CD123/CD16A for AML), plus the ROCK platform for customizable ICEs, ongoing clinical trials, and partnerships with pharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affimed company profile →
BlossomHill Therapeutics Logo

BlossomHill Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies focused on oncology and autoimmune disorders, including FDA-approved repotrectinib (AUGTYRO) for ROS1+ NSCLC, crizotinib (XALKORI) and lorlatinib (LORBRENA), and pipeline candidates elzovantinib (TPX-0022) and TPX-0046, both in Phase 1 studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BlossomHill Therapeutics company profile →
Kite Pharma Logo

Kite Pharma

HQ: United States Website
  • Description: Provider of immune-based targeted cancer therapies, including personalized CAR T-cell treatments that stimulate patients' immune systems. Offerings include Yescarta for certain relapsed or refractory large B-cell lymphoma and follicular lymphoma, and Tecartus for relapsed or refractory mantle cell lymphoma and B-cell precursor acute lymphoblastic leukemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kite Pharma company profile →
Caelum Biosciences Logo

Caelum Biosciences

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology developing treatments for rare and life-threatening diseases, with lead asset CAEL-101 (mAb 11-1F4), a novel antibody licensed from Columbia University in January 2017 for the treatment of amyloid light chain (AL) amyloidosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caelum Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nuvalent

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nuvalent

2.2 - Growth funds investing in similar companies to Nuvalent

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nuvalent

4.2 - Public trading comparable groups for Nuvalent

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nuvalent

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nuvalent

What does Nuvalent do?

Nuvalent is a provider of targeted therapies for clinically proven kinase targets in cancer.

Who are Nuvalent's competitors?

Nuvalent's competitors and similar companies include Shattuck Labs, Affimed, BlossomHill Therapeutics, Kite Pharma, and Caelum Biosciences.

Where is Nuvalent headquartered?

Nuvalent is headquartered in United States.

How many employees does Nuvalent have?

Nuvalent has 1,000 employees 🔒.

When was Nuvalent founded?

Nuvalent was founded in 2010 🔒.

What sector and industry vertical is Nuvalent in?

Nuvalent is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nuvalent

Who are the top strategic acquirers in Nuvalent's sector and industry

Top strategic M&A buyers and acquirers in Nuvalent's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nuvalent?

Top strategic M&A buyers groups and sectors for Nuvalent include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nuvalent's sector and industry vertical

Which are the top PE firms investing in Nuvalent's sector and industry vertical?

Top PE firms investing in Nuvalent's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nuvalent's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nuvalent's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nuvalent's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nuvalent include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nuvalent's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nuvalent?

The key public trading comparables and valuation benchmarks for Nuvalent include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nuvalent for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nuvalent with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nuvalent's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nuvalent with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nuvalent's' sector and industry vertical?

Access recent funding rounds and capital raises in Nuvalent's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nuvalent